Board Approves Final dividend for the FY 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Sandu Pharmaceuticals has recommended a final dividend of Rs. 0.80 per equity share, which works out to 8% on the paid-up face value of Rs. 10 per share, for the financial year ended March 31, 2025. This recommendation is subject to approval by shareholders at the upcoming Annual General Meeting. The company has stated that the AGM date, record date (cut-off for eligibility), and actual dividend payment date will be communicated separately. The decision was taken at a board meeting held on May 28, 2025, and follows an earlier intimation dated May 17, 2025.
This is a modest dividend payout, reflecting steady but conservative cash returns to shareholders. Investors holding shares on the record date will receive Rs. 0.80 per share. The attractiveness of this dividend depends on the current market price of the stock — the actual yield percentage cannot be determined from this filing alone.